Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W E Haefeli

Showing results (101-110 of 132) with videos related to

Pageof 14
Sort By:
British Journal of Clinical Pharmacology|September 6, 2000
Effect of P-glycoprotein modulation on the clinical pharmacokinetics and adverse effects of morphineJ Drewe, H A Ball, C Beglinger, et al.
European Journal of Clinical Pharmacology|September 6, 2007
Detection and prevention of prescriptions with excessive doses in electronic prescribing systemsH M Seidling, A Al Barmawi, J Kaltschmidt, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 1, 1996
Low whole-blood S-adenosylmethionine and correlation between 5-methyltetrahydrofolate and homocysteine in coronary artery diseaseF M Loehrer, C P Angst, W E Haefeli, et al.
Clinical Pharmacology and Therapeutics|November 20, 2009
Effect of simultaneous induction and inhibition of CYP3A by St John's Wort and ritonavir on CYP3A activityV Hafner, M Jäger, A-K Matthée, et al.
Clinical Pharmacology and Therapeutics|July 1, 1996
N-acetyltransferase 2 polymorphism in patients infected with human immunodeficiency virusG R Kaufmann, M Wenk, W Taeschner, et al.
Circulation|March 1, 1995
Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivoR Joannides, W E Haefeli, L Linder, et al.
Atherosclerosis|January 4, 2001
Disturbed ratio of erythrocyte and plasma S-adenosylmethionine/S-adenosylhomocysteine in peripheral arterial occlusive diseaseF M Loehrer, M Tschöpl, C P Angst, et al.
Clinical Pharmacology and Therapeutics|April 1, 1993
Glutathione S-transferase mu polymorphism does not explain variation in nitroglycerin responsivenessW E Haefeli, N Srivastava, K T Kelsey, et al.
Clinical Pharmacology and Therapeutics|November 24, 2001
Ritonavir increases loperamide plasma concentrations without evidence for P-glycoprotein involvementY Tayrouz, B Ganssmann, R Ding, et al.
Analytical and Bioanalytical Chemistry|November 1, 2008
A systematic comparison of four different workup procedures for systematic toxicological analysis of urine samples using gas chromatography-mass spectrometryF T Peters, O Drvarov, S Lottner, et al.
Pageof 14

Showing results (101-110 of 132) with videos related to

Sort By:
Pageof 14
British Journal of Clinical Pharmacology|September 6, 2000
Effect of P-glycoprotein modulation on the clinical pharmacokinetics and adverse effects of morphineJ Drewe, H A Ball, C Beglinger, et al.
European Journal of Clinical Pharmacology|September 6, 2007
Detection and prevention of prescriptions with excessive doses in electronic prescribing systemsH M Seidling, A Al Barmawi, J Kaltschmidt, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 1, 1996
Low whole-blood S-adenosylmethionine and correlation between 5-methyltetrahydrofolate and homocysteine in coronary artery diseaseF M Loehrer, C P Angst, W E Haefeli, et al.
Clinical Pharmacology and Therapeutics|November 20, 2009
Effect of simultaneous induction and inhibition of CYP3A by St John's Wort and ritonavir on CYP3A activityV Hafner, M Jäger, A-K Matthée, et al.
Clinical Pharmacology and Therapeutics|July 1, 1996
N-acetyltransferase 2 polymorphism in patients infected with human immunodeficiency virusG R Kaufmann, M Wenk, W Taeschner, et al.
Circulation|March 1, 1995
Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivoR Joannides, W E Haefeli, L Linder, et al.
Atherosclerosis|January 4, 2001
Disturbed ratio of erythrocyte and plasma S-adenosylmethionine/S-adenosylhomocysteine in peripheral arterial occlusive diseaseF M Loehrer, M Tschöpl, C P Angst, et al.
Clinical Pharmacology and Therapeutics|April 1, 1993
Glutathione S-transferase mu polymorphism does not explain variation in nitroglycerin responsivenessW E Haefeli, N Srivastava, K T Kelsey, et al.
Clinical Pharmacology and Therapeutics|November 24, 2001
Ritonavir increases loperamide plasma concentrations without evidence for P-glycoprotein involvementY Tayrouz, B Ganssmann, R Ding, et al.
Analytical and Bioanalytical Chemistry|November 1, 2008
A systematic comparison of four different workup procedures for systematic toxicological analysis of urine samples using gas chromatography-mass spectrometryF T Peters, O Drvarov, S Lottner, et al.
Pageof 14